Alternatives to PCI Pharma Services
PCI Pharma Services is a Pharmaceuticals tool: A leading global contract development and manufacturing organization (CDMO) for innovative biologic and small molecule therapies. Here are the 58 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Pharmaceuticals companies to PCI Pharma Services
Azurity PharmaceuticalsNot ratedAzurity Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing high-quality, affordable liquid medications.
Advanced Accelerator ApplicationsNot ratedDevelops, manufactures, and markets radiopharmaceuticals for diagnostic and therapeutic applications.
- APApimeds PharmaceuticalsNot rated
Pharmaceutical company focused on merger and financing activities.
iDEL Therapeutics3.0 out of 5 (1)Developing a pipeline of cancer therapeutics delivered directly into the cytosol of tumor cells.
ImperagenNot ratedBiotech company developing novel drug delivery technologies.
EthypharmNot ratedInternational specialty pharmaceutical company focused on central nervous system, pain management, and addiction treatments.
Moderna2.5 out of 5 (2)Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
- VEVertice Pharma, LLCNot rated
Pharma company
- JUJuno TherapeuticsNot rated
Biotechnology company focused on developing cancer immunotherapies.
Kite PharmaNot ratedBiotechnology company developing and commercializing cell therapies for cancer treatment.
CRISPR TherapeuticsNot ratedBiotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology.
Seaport TherapeuticsNot ratedDeveloping novel therapeutics to restore gut lymphatic function.
ElicitNot ratedAI-powered research assistant for scientific literature review and data extraction.
Johnson & JohnsonNot ratedA global leader in healthcare, developing innovative solutions for consumer health, pharmaceuticals, and medical devices.
Degron TherapeuticsNot ratedClinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.
- CRCreate MedicinesNot rated
Developing in vivo immunotherapies for autoimmune diseases and cancer.
InfinimmuneNot ratedDeveloping human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.
AdcendoNot ratedDeveloping first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.
EnteromeNot ratedClinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.
CellCentricNot ratedA clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.
Showing the next 20 closest matches. See the rest on the PCI Pharma Services profile.
Sponsored rows are paid and labelled. Advertise on this page

